Skip to content
Screener

Treace Medical Concepts, Inc. TMCI Q1 2026 earnings

Reported May 8, 2026 · Before market open

Revenue$47.2MBeat by $1.2M
EPS-$0.28Beat by $0.03
Revenue estimate$46.0M
EPS estimate-$0.31

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$47.7M
EPS estimate-$0.26

Financials

Q1 2026

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$86.55M-83.5%
Enterprise value$148.61M-74.4%
P/S0.4×-2.1×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

FAQ

When did Treace Medical Concepts, Inc. report Q1 2026 earnings?
Treace Medical Concepts, Inc. (TMCI) reported Q1 2026 earnings on May 8, 2026 before market open.
What were Treace Medical Concepts, Inc.'s Q1 2026 revenue and EPS?
Treace Medical Concepts, Inc. reported revenue of $47.2M and eps of $-0.28 for Q1 2026.
Did Treace Medical Concepts, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $46.0M by $1.2M. EPS beat the consensus estimate of $-0.31 by $0.03.
How did Treace Medical Concepts, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 10.2% from $52.6M a year earlier and eps declined 12.0% from $-0.25.
Where can I find Treace Medical Concepts, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-213267) and the 10-Q periodic report (0001193125-26-213322) directly on SEC EDGAR. The filing index links above go to sec.gov.